nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—Phenprocoumon—Phenytoin—epilepsy syndrome	0.0955	1	CrCrCtD
Tolterodine—CHRM3—epilepsy syndrome	0.0713	0.285	CbGaD
Tolterodine—multiple sclerosis—Oxcarbazepine—epilepsy syndrome	0.0696	0.213	CpDpCtD
Tolterodine—multiple sclerosis—Diazepam—epilepsy syndrome	0.0696	0.213	CpDpCtD
Tolterodine—CHRM1—epilepsy syndrome	0.0665	0.266	CbGaD
Tolterodine—multiple sclerosis—Pregabalin—epilepsy syndrome	0.0592	0.181	CpDpCtD
Tolterodine—CHRM2—epilepsy syndrome	0.0543	0.217	CbGaD
Tolterodine—multiple sclerosis—Carbamazepine—epilepsy syndrome	0.0528	0.161	CpDpCtD
Tolterodine—multiple sclerosis—Clonazepam—epilepsy syndrome	0.0422	0.129	CpDpCtD
Tolterodine—multiple sclerosis—Gabapentin—epilepsy syndrome	0.034	0.104	CpDpCtD
Tolterodine—CYP2C19—epilepsy syndrome	0.0335	0.134	CbGaD
Tolterodine—CYP2D6—epilepsy syndrome	0.0249	0.0992	CbGaD
Tolterodine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0104	0.0516	CbGbCtD
Tolterodine—CYP2C19—Felbamate—epilepsy syndrome	0.00971	0.0479	CbGbCtD
Tolterodine—CYP2C19—Trimethadione—epilepsy syndrome	0.00971	0.0479	CbGbCtD
Tolterodine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00913	0.0451	CbGbCtD
Tolterodine—CYP2C9—Trimethadione—epilepsy syndrome	0.00807	0.0398	CbGbCtD
Tolterodine—CYP2C19—Clobazam—epilepsy syndrome	0.00792	0.0391	CbGbCtD
Tolterodine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00759	0.0375	CbGbCtD
Tolterodine—CYP2C19—Carbamazepine—epilepsy syndrome	0.00656	0.0324	CbGbCtD
Tolterodine—CYP2C19—Primidone—epilepsy syndrome	0.00612	0.0302	CbGbCtD
Tolterodine—CYP2C19—Phenytoin—epilepsy syndrome	0.00588	0.029	CbGbCtD
Tolterodine—CYP2C19—Propofol—epilepsy syndrome	0.00549	0.0271	CbGbCtD
Tolterodine—CYP2C9—Carbamazepine—epilepsy syndrome	0.00545	0.0269	CbGbCtD
Tolterodine—CYP2C19—Phenobarbital—epilepsy syndrome	0.00524	0.0259	CbGbCtD
Tolterodine—CYP2C9—Primidone—epilepsy syndrome	0.00509	0.0251	CbGbCtD
Tolterodine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00505	0.0249	CbGbCtD
Tolterodine—CYP2C19—Diazepam—epilepsy syndrome	0.00497	0.0245	CbGbCtD
Tolterodine—CYP2C9—Phenytoin—epilepsy syndrome	0.00489	0.0241	CbGbCtD
Tolterodine—CYP2C19—Zonisamide—epilepsy syndrome	0.00485	0.0239	CbGbCtD
Tolterodine—CYP3A4—Trimethadione—epilepsy syndrome	0.00469	0.0232	CbGbCtD
Tolterodine—CYP3A4—Felbamate—epilepsy syndrome	0.00469	0.0232	CbGbCtD
Tolterodine—CYP2C9—Propofol—epilepsy syndrome	0.00456	0.0225	CbGbCtD
Tolterodine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00441	0.0218	CbGbCtD
Tolterodine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00436	0.0215	CbGbCtD
Tolterodine—CYP2D6—Propofol—epilepsy syndrome	0.00417	0.0206	CbGbCtD
Tolterodine—CYP2C9—Diazepam—epilepsy syndrome	0.00413	0.0204	CbGbCtD
Tolterodine—CYP3A4—Clonazepam—epilepsy syndrome	0.00399	0.0197	CbGbCtD
Tolterodine—CYP2C19—Valproic Acid—epilepsy syndrome	0.00392	0.0193	CbGbCtD
Tolterodine—CYP3A4—Clobazam—epilepsy syndrome	0.00383	0.0189	CbGbCtD
Tolterodine—CYP2C19—Topiramate—epilepsy syndrome	0.00354	0.0175	CbGbCtD
Tolterodine—CYP2C9—Valproic Acid—epilepsy syndrome	0.00326	0.0161	CbGbCtD
Tolterodine—CYP3A4—Rufinamide—epilepsy syndrome	0.00325	0.0161	CbGbCtD
Tolterodine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00317	0.0157	CbGbCtD
Tolterodine—CYP3A4—Primidone—epilepsy syndrome	0.00296	0.0146	CbGbCtD
Tolterodine—CYP3A4—Phenytoin—epilepsy syndrome	0.00284	0.014	CbGbCtD
Tolterodine—CYP3A4—Propofol—epilepsy syndrome	0.00265	0.0131	CbGbCtD
Tolterodine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00254	0.0125	CbGbCtD
Tolterodine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00254	0.0125	CbGbCtD
Tolterodine—CYP3A4—Midazolam—epilepsy syndrome	0.0025	0.0123	CbGbCtD
Tolterodine—CYP3A4—Diazepam—epilepsy syndrome	0.0024	0.0119	CbGbCtD
Tolterodine—CYP3A4—Zonisamide—epilepsy syndrome	0.00235	0.0116	CbGbCtD
Tolterodine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00189	0.00935	CbGbCtD
Tolterodine—CYP3A4—Topiramate—epilepsy syndrome	0.00171	0.00844	CbGbCtD
Tolterodine—Disopyramide—KCND2—epilepsy syndrome	0.000361	0.168	CrCbGaD
Tolterodine—Fesoterodine—CHRM3—epilepsy syndrome	0.000223	0.103	CrCbGaD
Tolterodine—Fesoterodine—CHRM1—epilepsy syndrome	0.000208	0.0963	CrCbGaD
Tolterodine—CHRM4—head—epilepsy syndrome	0.000196	0.041	CbGeAlD
Tolterodine—CHRM4—nervous system—epilepsy syndrome	0.000186	0.0388	CbGeAlD
Tolterodine—CHRM2—forebrain—epilepsy syndrome	0.000184	0.0384	CbGeAlD
Tolterodine—CHRM4—central nervous system—epilepsy syndrome	0.000179	0.0374	CbGeAlD
Tolterodine—Fesoterodine—CHRM2—epilepsy syndrome	0.000169	0.0787	CrCbGaD
Tolterodine—CHRM2—telencephalon—epilepsy syndrome	0.000169	0.0353	CbGeAlD
Tolterodine—CHRM1—forebrain—epilepsy syndrome	0.000167	0.0349	CbGeAlD
Tolterodine—CHRM1—telencephalon—epilepsy syndrome	0.000154	0.0321	CbGeAlD
Tolterodine—CHRM5—head—epilepsy syndrome	0.000153	0.032	CbGeAlD
Tolterodine—CHRM3—forebrain—epilepsy syndrome	0.00015	0.0313	CbGeAlD
Tolterodine—CYP2D6—hindbrain—epilepsy syndrome	0.000146	0.0306	CbGeAlD
Tolterodine—CHRM5—nervous system—epilepsy syndrome	0.000145	0.0304	CbGeAlD
Tolterodine—CHRM4—brain—epilepsy syndrome	0.000142	0.0297	CbGeAlD
Tolterodine—CHRM5—central nervous system—epilepsy syndrome	0.00014	0.0292	CbGeAlD
Tolterodine—CHRM3—telencephalon—epilepsy syndrome	0.000138	0.0288	CbGeAlD
Tolterodine—KCNH2—forebrain—epilepsy syndrome	0.000133	0.0277	CbGeAlD
Tolterodine—KCNH2—telencephalon—epilepsy syndrome	0.000122	0.0255	CbGeAlD
Tolterodine—CHRM5—brain—epilepsy syndrome	0.000111	0.0232	CbGeAlD
Tolterodine—CHRM2—head—epilepsy syndrome	0.000105	0.022	CbGeAlD
Tolterodine—Orphenadrine—SCN9A—epilepsy syndrome	0.000104	0.0481	CrCbGaD
Tolterodine—CHRM2—nervous system—epilepsy syndrome	9.98e-05	0.0208	CbGeAlD
Tolterodine—Disopyramide—CHRM3—epilepsy syndrome	9.94e-05	0.0461	CrCbGaD
Tolterodine—CHRM2—central nervous system—epilepsy syndrome	9.61e-05	0.0201	CbGeAlD
Tolterodine—KCNH2—medulla oblongata—epilepsy syndrome	9.6e-05	0.02	CbGeAlD
Tolterodine—CHRM1—head—epilepsy syndrome	9.58e-05	0.02	CbGeAlD
Tolterodine—Orphenadrine—SCN4A—epilepsy syndrome	9.53e-05	0.0442	CrCbGaD
Tolterodine—Disopyramide—CHRM1—epilepsy syndrome	9.27e-05	0.043	CrCbGaD
Tolterodine—CHRM1—nervous system—epilepsy syndrome	9.09e-05	0.019	CbGeAlD
Tolterodine—KCNH2—midbrain—epilepsy syndrome	8.77e-05	0.0183	CbGeAlD
Tolterodine—CHRM1—central nervous system—epilepsy syndrome	8.75e-05	0.0183	CbGeAlD
Tolterodine—CHRM3—head—epilepsy syndrome	8.58e-05	0.0179	CbGeAlD
Tolterodine—KCNH2—spinal cord—epilepsy syndrome	8.56e-05	0.0179	CbGeAlD
Tolterodine—CYP2D6—brainstem—epilepsy syndrome	8.39e-05	0.0175	CbGeAlD
Tolterodine—CHRM3—nervous system—epilepsy syndrome	8.13e-05	0.017	CbGeAlD
Tolterodine—CYP2D6—forebrain—epilepsy syndrome	8.1e-05	0.0169	CbGeAlD
Tolterodine—CHRM3—central nervous system—epilepsy syndrome	7.83e-05	0.0163	CbGeAlD
Tolterodine—Fesoterodine—CYP2D6—epilepsy syndrome	7.75e-05	0.036	CrCbGaD
Tolterodine—CHRM2—brain—epilepsy syndrome	7.63e-05	0.0159	CbGeAlD
Tolterodine—KCNH2—head—epilepsy syndrome	7.6e-05	0.0159	CbGeAlD
Tolterodine—Disopyramide—CHRM2—epilepsy syndrome	7.57e-05	0.0351	CrCbGaD
Tolterodine—CYP2D6—telencephalon—epilepsy syndrome	7.45e-05	0.0155	CbGeAlD
Tolterodine—Brompheniramine—CHRM3—epilepsy syndrome	7.39e-05	0.0343	CrCbGaD
Tolterodine—Urinary tract infection—Gabapentin—epilepsy syndrome	7.24e-05	0.00102	CcSEcCtD
Tolterodine—Feeling abnormal—Vigabatrin—epilepsy syndrome	7.21e-05	0.00102	CcSEcCtD
Tolterodine—Oedema—Lamotrigine—epilepsy syndrome	7.21e-05	0.00102	CcSEcCtD
Tolterodine—KCNH2—nervous system—epilepsy syndrome	7.21e-05	0.0151	CbGeAlD
Tolterodine—Fatigue—Felbamate—epilepsy syndrome	7.19e-05	0.00101	CcSEcCtD
Tolterodine—Dyspepsia—Zonisamide—epilepsy syndrome	7.19e-05	0.00101	CcSEcCtD
Tolterodine—Oedema peripheral—Pregabalin—epilepsy syndrome	7.18e-05	0.00101	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	7.17e-05	0.00101	CcSEcCtD
Tolterodine—Infection—Lamotrigine—epilepsy syndrome	7.16e-05	0.00101	CcSEcCtD
Tolterodine—Gastrointestinal pain—Vigabatrin—epilepsy syndrome	7.16e-05	0.00101	CcSEcCtD
Tolterodine—Constipation—Felbamate—epilepsy syndrome	7.13e-05	0.001	CcSEcCtD
Tolterodine—Pain—Felbamate—epilepsy syndrome	7.13e-05	0.001	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	7.12e-05	0.001	CcSEcCtD
Tolterodine—Feeling abnormal—Diazepam—epilepsy syndrome	7.1e-05	0.001	CcSEcCtD
Tolterodine—Diarrhoea—Acetazolamide—epilepsy syndrome	7.09e-05	0.000999	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	7.08e-05	0.000998	CcSEcCtD
Tolterodine—Gastrointestinal pain—Diazepam—epilepsy syndrome	7.05e-05	0.000993	CcSEcCtD
Tolterodine—Fatigue—Zonisamide—epilepsy syndrome	7.04e-05	0.000991	CcSEcCtD
Tolterodine—Tachycardia—Lamotrigine—epilepsy syndrome	7.04e-05	0.000991	CcSEcCtD
Tolterodine—Visual impairment—Pregabalin—epilepsy syndrome	7.03e-05	0.00099	CcSEcCtD
Tolterodine—Somnolence—Clonazepam—epilepsy syndrome	7e-05	0.000985	CcSEcCtD
Tolterodine—Sinusitis—Gabapentin—epilepsy syndrome	6.99e-05	0.000984	CcSEcCtD
Tolterodine—Constipation—Zonisamide—epilepsy syndrome	6.98e-05	0.000983	CcSEcCtD
Tolterodine—Orphenadrine—SCN1A—epilepsy syndrome	6.96e-05	0.0323	CrCbGaD
Tolterodine—Somnolence—Phenytoin—epilepsy syndrome	6.95e-05	0.000979	CcSEcCtD
Tolterodine—CHRM1—brain—epilepsy syndrome	6.94e-05	0.0145	CbGeAlD
Tolterodine—Hypersensitivity—Midazolam—epilepsy syndrome	6.94e-05	0.000978	CcSEcCtD
Tolterodine—KCNH2—central nervous system—epilepsy syndrome	6.94e-05	0.0145	CbGeAlD
Tolterodine—Dyspepsia—Clonazepam—epilepsy syndrome	6.93e-05	0.000976	CcSEcCtD
Tolterodine—Abdominal pain—Vigabatrin—epilepsy syndrome	6.92e-05	0.000975	CcSEcCtD
Tolterodine—Flatulence—Valproic Acid—epilepsy syndrome	6.92e-05	0.000974	CcSEcCtD
Tolterodine—Somnolence—Oxcarbazepine—epilepsy syndrome	6.91e-05	0.000974	CcSEcCtD
Tolterodine—Asthenia—Propofol—epilepsy syndrome	6.91e-05	0.000973	CcSEcCtD
Tolterodine—Brompheniramine—CHRM1—epilepsy syndrome	6.89e-05	0.032	CrCbGaD
Tolterodine—Dyspepsia—Phenytoin—epilepsy syndrome	6.88e-05	0.000969	CcSEcCtD
Tolterodine—Feeling abnormal—Felbamate—epilepsy syndrome	6.87e-05	0.000968	CcSEcCtD
Tolterodine—Dizziness—Acetazolamide—epilepsy syndrome	6.86e-05	0.000966	CcSEcCtD
Tolterodine—Hypersensitivity—Levetiracetam—epilepsy syndrome	6.86e-05	0.000966	CcSEcCtD
Tolterodine—Dyspepsia—Oxcarbazepine—epilepsy syndrome	6.84e-05	0.000964	CcSEcCtD
Tolterodine—Gastrointestinal pain—Felbamate—epilepsy syndrome	6.82e-05	0.000961	CcSEcCtD
Tolterodine—Abdominal pain—Diazepam—epilepsy syndrome	6.81e-05	0.00096	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	6.8e-05	0.000957	CcSEcCtD
Tolterodine—KCNH2—cerebellum—epilepsy syndrome	6.78e-05	0.0142	CbGeAlD
Tolterodine—Fatigue—Clonazepam—epilepsy syndrome	6.78e-05	0.000956	CcSEcCtD
Tolterodine—Flushing—Pregabalin—epilepsy syndrome	6.77e-05	0.000953	CcSEcCtD
Tolterodine—Asthenia—Midazolam—epilepsy syndrome	6.76e-05	0.000952	CcSEcCtD
Tolterodine—Bronchitis—Topiramate—epilepsy syndrome	6.76e-05	0.000952	CcSEcCtD
Tolterodine—Fatigue—Phenytoin—epilepsy syndrome	6.74e-05	0.000949	CcSEcCtD
Tolterodine—Pain—Clonazepam—epilepsy syndrome	6.73e-05	0.000948	CcSEcCtD
Tolterodine—Constipation—Clonazepam—epilepsy syndrome	6.73e-05	0.000948	CcSEcCtD
Tolterodine—Feeling abnormal—Zonisamide—epilepsy syndrome	6.73e-05	0.000948	CcSEcCtD
Tolterodine—Fatigue—Oxcarbazepine—epilepsy syndrome	6.7e-05	0.000944	CcSEcCtD
Tolterodine—Constipation—Phenytoin—epilepsy syndrome	6.68e-05	0.000941	CcSEcCtD
Tolterodine—Gastrointestinal pain—Zonisamide—epilepsy syndrome	6.68e-05	0.00094	CcSEcCtD
Tolterodine—Asthenia—Levetiracetam—epilepsy syndrome	6.68e-05	0.00094	CcSEcCtD
Tolterodine—Hallucination—Gabapentin—epilepsy syndrome	6.65e-05	0.000937	CcSEcCtD
Tolterodine—Pain—Oxcarbazepine—epilepsy syndrome	6.65e-05	0.000936	CcSEcCtD
Tolterodine—Constipation—Oxcarbazepine—epilepsy syndrome	6.65e-05	0.000936	CcSEcCtD
Tolterodine—Somnolence—Carbamazepine—epilepsy syndrome	6.63e-05	0.000934	CcSEcCtD
Tolterodine—Abdominal pain—Felbamate—epilepsy syndrome	6.59e-05	0.000929	CcSEcCtD
Tolterodine—Diarrhoea—Propofol—epilepsy syndrome	6.59e-05	0.000928	CcSEcCtD
Tolterodine—Oedema peripheral—Gabapentin—epilepsy syndrome	6.59e-05	0.000928	CcSEcCtD
Tolterodine—Dysuria—Topiramate—epilepsy syndrome	6.57e-05	0.000926	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	6.57e-05	0.000925	CcSEcCtD
Tolterodine—Dyspepsia—Carbamazepine—epilepsy syndrome	6.57e-05	0.000925	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Topiramate—epilepsy syndrome	6.53e-05	0.00092	CcSEcCtD
Tolterodine—Headache—Acetazolamide—epilepsy syndrome	6.5e-05	0.000915	CcSEcCtD
Tolterodine—Feeling abnormal—Clonazepam—epilepsy syndrome	6.48e-05	0.000913	CcSEcCtD
Tolterodine—Abdominal pain—Zonisamide—epilepsy syndrome	6.45e-05	0.000909	CcSEcCtD
Tolterodine—Hypersensitivity—Vigabatrin—epilepsy syndrome	6.45e-05	0.000908	CcSEcCtD
Tolterodine—Asthenia—Fosphenytoin—epilepsy syndrome	6.44e-05	0.000908	CcSEcCtD
Tolterodine—Visual impairment—Gabapentin—epilepsy syndrome	6.44e-05	0.000908	CcSEcCtD
Tolterodine—Feeling abnormal—Phenytoin—epilepsy syndrome	6.44e-05	0.000907	CcSEcCtD
Tolterodine—Gastrointestinal pain—Clonazepam—epilepsy syndrome	6.43e-05	0.000906	CcSEcCtD
Tolterodine—Fatigue—Carbamazepine—epilepsy syndrome	6.43e-05	0.000906	CcSEcCtD
Tolterodine—Angioedema—Valproic Acid—epilepsy syndrome	6.41e-05	0.000904	CcSEcCtD
Tolterodine—Somnolence—Lamotrigine—epilepsy syndrome	6.41e-05	0.000903	CcSEcCtD
Tolterodine—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	6.41e-05	0.000902	CcSEcCtD
Tolterodine—Weight increased—Topiramate—epilepsy syndrome	6.4e-05	0.000901	CcSEcCtD
Tolterodine—Constipation—Carbamazepine—epilepsy syndrome	6.38e-05	0.000899	CcSEcCtD
Tolterodine—Pain—Carbamazepine—epilepsy syndrome	6.38e-05	0.000899	CcSEcCtD
Tolterodine—Dizziness—Propofol—epilepsy syndrome	6.37e-05	0.000897	CcSEcCtD
Tolterodine—Diarrhoea—Levetiracetam—epilepsy syndrome	6.37e-05	0.000897	CcSEcCtD
Tolterodine—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	6.36e-05	0.000895	CcSEcCtD
Tolterodine—Hypersensitivity—Diazepam—epilepsy syndrome	6.35e-05	0.000894	CcSEcCtD
Tolterodine—Dyspepsia—Lamotrigine—epilepsy syndrome	6.35e-05	0.000894	CcSEcCtD
Tolterodine—Vertigo—Valproic Acid—epilepsy syndrome	6.31e-05	0.000888	CcSEcCtD
Tolterodine—Asthenia—Vigabatrin—epilepsy syndrome	6.28e-05	0.000885	CcSEcCtD
Tolterodine—Flatulence—Pregabalin—epilepsy syndrome	6.25e-05	0.000881	CcSEcCtD
Tolterodine—Dizziness—Midazolam—epilepsy syndrome	6.23e-05	0.000878	CcSEcCtD
Tolterodine—Abdominal pain—Clonazepam—epilepsy syndrome	6.22e-05	0.000876	CcSEcCtD
Tolterodine—Fatigue—Lamotrigine—epilepsy syndrome	6.22e-05	0.000876	CcSEcCtD
Tolterodine—CHRM3—brain—epilepsy syndrome	6.21e-05	0.013	CbGeAlD
Tolterodine—Palpitations—Valproic Acid—epilepsy syndrome	6.2e-05	0.000874	CcSEcCtD
Tolterodine—Asthenia—Diazepam—epilepsy syndrome	6.18e-05	0.000871	CcSEcCtD
Tolterodine—Constipation—Lamotrigine—epilepsy syndrome	6.17e-05	0.000869	CcSEcCtD
Tolterodine—Pain—Lamotrigine—epilepsy syndrome	6.17e-05	0.000869	CcSEcCtD
Tolterodine—Dizziness—Levetiracetam—epilepsy syndrome	6.15e-05	0.000867	CcSEcCtD
Tolterodine—Feeling abnormal—Carbamazepine—epilepsy syndrome	6.15e-05	0.000866	CcSEcCtD
Tolterodine—Abdominal pain—Oxcarbazepine—epilepsy syndrome	6.15e-05	0.000866	CcSEcCtD
Tolterodine—Diarrhoea—Fosphenytoin—epilepsy syndrome	6.14e-05	0.000865	CcSEcCtD
Tolterodine—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	6.1e-05	0.000859	CcSEcCtD
Tolterodine—Urinary tract infection—Topiramate—epilepsy syndrome	6.09e-05	0.000858	CcSEcCtD
Tolterodine—Headache—Propofol—epilepsy syndrome	6.03e-05	0.00085	CcSEcCtD
Tolterodine—Hypersensitivity—Zonisamide—epilepsy syndrome	6.02e-05	0.000847	CcSEcCtD
Tolterodine—Diarrhoea—Vigabatrin—epilepsy syndrome	5.99e-05	0.000844	CcSEcCtD
Tolterodine—Asthenia—Felbamate—epilepsy syndrome	5.98e-05	0.000843	CcSEcCtD
Tolterodine—Chest pain—Valproic Acid—epilepsy syndrome	5.98e-05	0.000842	CcSEcCtD
Tolterodine—Arthralgia—Valproic Acid—epilepsy syndrome	5.98e-05	0.000842	CcSEcCtD
Tolterodine—Anxiety—Valproic Acid—epilepsy syndrome	5.96e-05	0.000839	CcSEcCtD
Tolterodine—Feeling abnormal—Lamotrigine—epilepsy syndrome	5.94e-05	0.000837	CcSEcCtD
Tolterodine—Dizziness—Fosphenytoin—epilepsy syndrome	5.94e-05	0.000836	CcSEcCtD
Tolterodine—Headache—Midazolam—epilepsy syndrome	5.9e-05	0.000831	CcSEcCtD
Tolterodine—Abdominal pain—Carbamazepine—epilepsy syndrome	5.9e-05	0.000831	CcSEcCtD
Tolterodine—Diarrhoea—Diazepam—epilepsy syndrome	5.9e-05	0.000831	CcSEcCtD
Tolterodine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	5.9e-05	0.000831	CcSEcCtD
Tolterodine—Sinusitis—Topiramate—epilepsy syndrome	5.88e-05	0.000828	CcSEcCtD
Tolterodine—Asthenia—Zonisamide—epilepsy syndrome	5.86e-05	0.000825	CcSEcCtD
Tolterodine—Dry mouth—Valproic Acid—epilepsy syndrome	5.85e-05	0.000823	CcSEcCtD
Tolterodine—Headache—Levetiracetam—epilepsy syndrome	5.83e-05	0.000821	CcSEcCtD
Tolterodine—Angioedema—Pregabalin—epilepsy syndrome	5.8e-05	0.000817	CcSEcCtD
Tolterodine—Hypersensitivity—Clonazepam—epilepsy syndrome	5.8e-05	0.000817	CcSEcCtD
Tolterodine—Dizziness—Vigabatrin—epilepsy syndrome	5.79e-05	0.000815	CcSEcCtD
Tolterodine—Confusional state—Valproic Acid—epilepsy syndrome	5.78e-05	0.000814	CcSEcCtD
Tolterodine—Hypersensitivity—Phenytoin—epilepsy syndrome	5.76e-05	0.000811	CcSEcCtD
Tolterodine—Flatulence—Gabapentin—epilepsy syndrome	5.73e-05	0.000808	CcSEcCtD
Tolterodine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	5.73e-05	0.000807	CcSEcCtD
Tolterodine—Oedema—Valproic Acid—epilepsy syndrome	5.73e-05	0.000807	CcSEcCtD
Tolterodine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	5.73e-05	0.000807	CcSEcCtD
Tolterodine—Diarrhoea—Felbamate—epilepsy syndrome	5.71e-05	0.000804	CcSEcCtD
Tolterodine—Vertigo—Pregabalin—epilepsy syndrome	5.7e-05	0.000803	CcSEcCtD
Tolterodine—Abdominal pain—Lamotrigine—epilepsy syndrome	5.7e-05	0.000803	CcSEcCtD
Tolterodine—Dizziness—Diazepam—epilepsy syndrome	5.7e-05	0.000803	CcSEcCtD
Tolterodine—Infection—Valproic Acid—epilepsy syndrome	5.69e-05	0.000802	CcSEcCtD
Tolterodine—Asthenia—Clonazepam—epilepsy syndrome	5.65e-05	0.000795	CcSEcCtD
Tolterodine—Headache—Fosphenytoin—epilepsy syndrome	5.63e-05	0.000792	CcSEcCtD
Tolterodine—Brompheniramine—CHRM2—epilepsy syndrome	5.63e-05	0.0261	CrCbGaD
Tolterodine—Palpitations—Pregabalin—epilepsy syndrome	5.61e-05	0.00079	CcSEcCtD
Tolterodine—Asthenia—Phenytoin—epilepsy syndrome	5.61e-05	0.00079	CcSEcCtD
Tolterodine—Hallucination—Topiramate—epilepsy syndrome	5.6e-05	0.000788	CcSEcCtD
Tolterodine—Tachycardia—Valproic Acid—epilepsy syndrome	5.59e-05	0.000788	CcSEcCtD
Tolterodine—Diarrhoea—Zonisamide—epilepsy syndrome	5.59e-05	0.000787	CcSEcCtD
Tolterodine—Asthenia—Oxcarbazepine—epilepsy syndrome	5.58e-05	0.000786	CcSEcCtD
Tolterodine—Oedema peripheral—Topiramate—epilepsy syndrome	5.54e-05	0.00078	CcSEcCtD
Tolterodine—Fesoterodine—ABCB1—epilepsy syndrome	5.54e-05	0.0257	CrCbGaD
Tolterodine—Dizziness—Felbamate—epilepsy syndrome	5.52e-05	0.000777	CcSEcCtD
Tolterodine—KCNH2—brain—epilepsy syndrome	5.51e-05	0.0115	CbGeAlD
Tolterodine—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.5e-05	0.000774	CcSEcCtD
Tolterodine—Headache—Vigabatrin—epilepsy syndrome	5.48e-05	0.000772	CcSEcCtD
Tolterodine—Visual impairment—Topiramate—epilepsy syndrome	5.42e-05	0.000764	CcSEcCtD
Tolterodine—Chest pain—Pregabalin—epilepsy syndrome	5.4e-05	0.000761	CcSEcCtD
Tolterodine—Arthralgia—Pregabalin—epilepsy syndrome	5.4e-05	0.000761	CcSEcCtD
Tolterodine—Dizziness—Zonisamide—epilepsy syndrome	5.4e-05	0.00076	CcSEcCtD
Tolterodine—Headache—Diazepam—epilepsy syndrome	5.4e-05	0.00076	CcSEcCtD
Tolterodine—Anxiety—Pregabalin—epilepsy syndrome	5.38e-05	0.000758	CcSEcCtD
Tolterodine—Diarrhoea—Clonazepam—epilepsy syndrome	5.38e-05	0.000758	CcSEcCtD
Tolterodine—Asthenia—Carbamazepine—epilepsy syndrome	5.35e-05	0.000754	CcSEcCtD
Tolterodine—Diarrhoea—Phenytoin—epilepsy syndrome	5.35e-05	0.000753	CcSEcCtD
Tolterodine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.32e-05	0.000749	CcSEcCtD
Tolterodine—Angioedema—Gabapentin—epilepsy syndrome	5.32e-05	0.000749	CcSEcCtD
Tolterodine—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.31e-05	0.000748	CcSEcCtD
Tolterodine—Dry mouth—Pregabalin—epilepsy syndrome	5.28e-05	0.000744	CcSEcCtD
Tolterodine—Vertigo—Gabapentin—epilepsy syndrome	5.23e-05	0.000737	CcSEcCtD
Tolterodine—Headache—Felbamate—epilepsy syndrome	5.23e-05	0.000736	CcSEcCtD
Tolterodine—Confusional state—Pregabalin—epilepsy syndrome	5.22e-05	0.000736	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.22e-05	0.000735	CcSEcCtD
Tolterodine—Flushing—Topiramate—epilepsy syndrome	5.22e-05	0.000735	CcSEcCtD
Tolterodine—Dizziness—Clonazepam—epilepsy syndrome	5.2e-05	0.000733	CcSEcCtD
Tolterodine—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.18e-05	0.00073	CcSEcCtD
Tolterodine—Oedema—Pregabalin—epilepsy syndrome	5.18e-05	0.00073	CcSEcCtD
Tolterodine—Asthenia—Lamotrigine—epilepsy syndrome	5.17e-05	0.000729	CcSEcCtD
Tolterodine—Dizziness—Phenytoin—epilepsy syndrome	5.17e-05	0.000728	CcSEcCtD
Tolterodine—Infection—Pregabalin—epilepsy syndrome	5.15e-05	0.000725	CcSEcCtD
Tolterodine—Palpitations—Gabapentin—epilepsy syndrome	5.14e-05	0.000724	CcSEcCtD
Tolterodine—Dizziness—Oxcarbazepine—epilepsy syndrome	5.14e-05	0.000724	CcSEcCtD
Tolterodine—Headache—Zonisamide—epilepsy syndrome	5.11e-05	0.00072	CcSEcCtD
Tolterodine—Diarrhoea—Carbamazepine—epilepsy syndrome	5.1e-05	0.000719	CcSEcCtD
Tolterodine—Somnolence—Valproic Acid—epilepsy syndrome	5.09e-05	0.000717	CcSEcCtD
Tolterodine—Tachycardia—Pregabalin—epilepsy syndrome	5.06e-05	0.000712	CcSEcCtD
Tolterodine—Dyspepsia—Valproic Acid—epilepsy syndrome	5.04e-05	0.00071	CcSEcCtD
Tolterodine—Chest pain—Gabapentin—epilepsy syndrome	4.95e-05	0.000698	CcSEcCtD
Tolterodine—Arthralgia—Gabapentin—epilepsy syndrome	4.95e-05	0.000698	CcSEcCtD
Tolterodine—Fatigue—Valproic Acid—epilepsy syndrome	4.94e-05	0.000696	CcSEcCtD
Tolterodine—Anxiety—Gabapentin—epilepsy syndrome	4.94e-05	0.000696	CcSEcCtD
Tolterodine—Dizziness—Carbamazepine—epilepsy syndrome	4.93e-05	0.000695	CcSEcCtD
Tolterodine—Diarrhoea—Lamotrigine—epilepsy syndrome	4.93e-05	0.000695	CcSEcCtD
Tolterodine—Headache—Clonazepam—epilepsy syndrome	4.93e-05	0.000694	CcSEcCtD
Tolterodine—Pain—Valproic Acid—epilepsy syndrome	4.9e-05	0.00069	CcSEcCtD
Tolterodine—Constipation—Valproic Acid—epilepsy syndrome	4.9e-05	0.00069	CcSEcCtD
Tolterodine—Headache—Phenytoin—epilepsy syndrome	4.9e-05	0.00069	CcSEcCtD
Tolterodine—Headache—Oxcarbazepine—epilepsy syndrome	4.87e-05	0.000686	CcSEcCtD
Tolterodine—Dry mouth—Gabapentin—epilepsy syndrome	4.85e-05	0.000683	CcSEcCtD
Tolterodine—Flatulence—Topiramate—epilepsy syndrome	4.82e-05	0.00068	CcSEcCtD
Tolterodine—Confusional state—Gabapentin—epilepsy syndrome	4.79e-05	0.000675	CcSEcCtD
Tolterodine—Dizziness—Lamotrigine—epilepsy syndrome	4.77e-05	0.000672	CcSEcCtD
Tolterodine—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.75e-05	0.000669	CcSEcCtD
Tolterodine—Oedema—Gabapentin—epilepsy syndrome	4.75e-05	0.000669	CcSEcCtD
Tolterodine—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.72e-05	0.000665	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.72e-05	0.000665	CcSEcCtD
Tolterodine—Infection—Gabapentin—epilepsy syndrome	4.72e-05	0.000665	CcSEcCtD
Tolterodine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.69e-05	0.00066	CcSEcCtD
Tolterodine—Headache—Carbamazepine—epilepsy syndrome	4.67e-05	0.000658	CcSEcCtD
Tolterodine—CYP2D6—head—epilepsy syndrome	4.64e-05	0.00968	CbGeAlD
Tolterodine—Tachycardia—Gabapentin—epilepsy syndrome	4.64e-05	0.000653	CcSEcCtD
Tolterodine—Somnolence—Pregabalin—epilepsy syndrome	4.6e-05	0.000649	CcSEcCtD
Tolterodine—Abdominal pain—Valproic Acid—epilepsy syndrome	4.53e-05	0.000638	CcSEcCtD
Tolterodine—Headache—Lamotrigine—epilepsy syndrome	4.52e-05	0.000636	CcSEcCtD
Tolterodine—CYP3A4—nervous system—epilepsy syndrome	4.47e-05	0.00933	CbGeAlD
Tolterodine—Fatigue—Pregabalin—epilepsy syndrome	4.47e-05	0.000629	CcSEcCtD
Tolterodine—Pain—Pregabalin—epilepsy syndrome	4.43e-05	0.000624	CcSEcCtD
Tolterodine—Constipation—Pregabalin—epilepsy syndrome	4.43e-05	0.000624	CcSEcCtD
Tolterodine—Vertigo—Topiramate—epilepsy syndrome	4.4e-05	0.00062	CcSEcCtD
Tolterodine—CYP2D6—nervous system—epilepsy syndrome	4.4e-05	0.00918	CbGeAlD
Tolterodine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.33e-05	0.00061	CcSEcCtD
Tolterodine—Palpitations—Topiramate—epilepsy syndrome	4.33e-05	0.000609	CcSEcCtD
Tolterodine—CYP3A4—central nervous system—epilepsy syndrome	4.3e-05	0.00898	CbGeAlD
Tolterodine—Feeling abnormal—Pregabalin—epilepsy syndrome	4.27e-05	0.000601	CcSEcCtD
Tolterodine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.24e-05	0.000597	CcSEcCtD
Tolterodine—CYP2D6—central nervous system—epilepsy syndrome	4.23e-05	0.00884	CbGeAlD
Tolterodine—Somnolence—Gabapentin—epilepsy syndrome	4.22e-05	0.000595	CcSEcCtD
Tolterodine—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.22e-05	0.000595	CcSEcCtD
Tolterodine—Dyspepsia—Gabapentin—epilepsy syndrome	4.18e-05	0.000589	CcSEcCtD
Tolterodine—Arthralgia—Topiramate—epilepsy syndrome	4.17e-05	0.000587	CcSEcCtD
Tolterodine—Chest pain—Topiramate—epilepsy syndrome	4.17e-05	0.000587	CcSEcCtD
Tolterodine—Anxiety—Topiramate—epilepsy syndrome	4.15e-05	0.000585	CcSEcCtD
Tolterodine—CYP2D6—cerebellum—epilepsy syndrome	4.14e-05	0.00864	CbGeAlD
Tolterodine—Asthenia—Valproic Acid—epilepsy syndrome	4.11e-05	0.000579	CcSEcCtD
Tolterodine—Fatigue—Gabapentin—epilepsy syndrome	4.1e-05	0.000577	CcSEcCtD
Tolterodine—Abdominal pain—Pregabalin—epilepsy syndrome	4.09e-05	0.000577	CcSEcCtD
Tolterodine—Dry mouth—Topiramate—epilepsy syndrome	4.08e-05	0.000574	CcSEcCtD
Tolterodine—Pain—Gabapentin—epilepsy syndrome	4.06e-05	0.000572	CcSEcCtD
Tolterodine—Constipation—Gabapentin—epilepsy syndrome	4.06e-05	0.000572	CcSEcCtD
Tolterodine—Confusional state—Topiramate—epilepsy syndrome	4.03e-05	0.000568	CcSEcCtD
Tolterodine—Oedema—Topiramate—epilepsy syndrome	4e-05	0.000563	CcSEcCtD
Tolterodine—Infection—Topiramate—epilepsy syndrome	3.97e-05	0.000559	CcSEcCtD
Tolterodine—Diarrhoea—Valproic Acid—epilepsy syndrome	3.92e-05	0.000552	CcSEcCtD
Tolterodine—Feeling abnormal—Gabapentin—epilepsy syndrome	3.91e-05	0.000551	CcSEcCtD
Tolterodine—Tachycardia—Topiramate—epilepsy syndrome	3.9e-05	0.000549	CcSEcCtD
Tolterodine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.88e-05	0.000547	CcSEcCtD
Tolterodine—Labetalol—CYP2D6—epilepsy syndrome	3.85e-05	0.0179	CrCbGaD
Tolterodine—Hypersensitivity—Pregabalin—epilepsy syndrome	3.82e-05	0.000538	CcSEcCtD
Tolterodine—Dizziness—Valproic Acid—epilepsy syndrome	3.79e-05	0.000534	CcSEcCtD
Tolterodine—Abdominal pain—Gabapentin—epilepsy syndrome	3.75e-05	0.000529	CcSEcCtD
Tolterodine—Asthenia—Pregabalin—epilepsy syndrome	3.72e-05	0.000523	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.64e-05	0.000513	CcSEcCtD
Tolterodine—Chlorphenamine—SLC6A4—epilepsy syndrome	3.6e-05	0.0167	CrCbGaD
Tolterodine—Headache—Valproic Acid—epilepsy syndrome	3.59e-05	0.000506	CcSEcCtD
Tolterodine—Somnolence—Topiramate—epilepsy syndrome	3.55e-05	0.0005	CcSEcCtD
Tolterodine—Diarrhoea—Pregabalin—epilepsy syndrome	3.54e-05	0.000499	CcSEcCtD
Tolterodine—Orphenadrine—CHRM2—epilepsy syndrome	3.54e-05	0.0165	CrCbGaD
Tolterodine—Dyspepsia—Topiramate—epilepsy syndrome	3.52e-05	0.000495	CcSEcCtD
Tolterodine—Hypersensitivity—Gabapentin—epilepsy syndrome	3.5e-05	0.000493	CcSEcCtD
Tolterodine—Brompheniramine—CYP2C19—epilepsy syndrome	3.47e-05	0.0161	CrCbGaD
Tolterodine—Fatigue—Topiramate—epilepsy syndrome	3.45e-05	0.000485	CcSEcCtD
Tolterodine—Dizziness—Pregabalin—epilepsy syndrome	3.43e-05	0.000482	CcSEcCtD
Tolterodine—Pain—Topiramate—epilepsy syndrome	3.42e-05	0.000481	CcSEcCtD
Tolterodine—Constipation—Topiramate—epilepsy syndrome	3.42e-05	0.000481	CcSEcCtD
Tolterodine—Asthenia—Gabapentin—epilepsy syndrome	3.41e-05	0.00048	CcSEcCtD
Tolterodine—CYP2D6—brain—epilepsy syndrome	3.36e-05	0.00702	CbGeAlD
Tolterodine—Feeling abnormal—Topiramate—epilepsy syndrome	3.29e-05	0.000464	CcSEcCtD
Tolterodine—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.27e-05	0.00046	CcSEcCtD
Tolterodine—Diarrhoea—Gabapentin—epilepsy syndrome	3.25e-05	0.000458	CcSEcCtD
Tolterodine—Headache—Pregabalin—epilepsy syndrome	3.24e-05	0.000457	CcSEcCtD
Tolterodine—Abdominal pain—Topiramate—epilepsy syndrome	3.16e-05	0.000445	CcSEcCtD
Tolterodine—Dizziness—Gabapentin—epilepsy syndrome	3.14e-05	0.000442	CcSEcCtD
Tolterodine—Atomoxetine—SLC6A4—epilepsy syndrome	3.02e-05	0.014	CrCbGaD
Tolterodine—Headache—Gabapentin—epilepsy syndrome	2.98e-05	0.000419	CcSEcCtD
Tolterodine—Hypersensitivity—Topiramate—epilepsy syndrome	2.94e-05	0.000415	CcSEcCtD
Tolterodine—Asthenia—Topiramate—epilepsy syndrome	2.87e-05	0.000404	CcSEcCtD
Tolterodine—Atomoxetine—CYP2C19—epilepsy syndrome	2.86e-05	0.0133	CrCbGaD
Tolterodine—Diarrhoea—Topiramate—epilepsy syndrome	2.73e-05	0.000385	CcSEcCtD
Tolterodine—Dizziness—Topiramate—epilepsy syndrome	2.64e-05	0.000372	CcSEcCtD
Tolterodine—Brompheniramine—CYP2D6—epilepsy syndrome	2.57e-05	0.0119	CrCbGaD
Tolterodine—Phenprocoumon—ALB—epilepsy syndrome	2.54e-05	0.0118	CrCbGaD
Tolterodine—Chlorphenamine—CYP2D6—epilepsy syndrome	2.53e-05	0.0117	CrCbGaD
Tolterodine—Headache—Topiramate—epilepsy syndrome	2.5e-05	0.000353	CcSEcCtD
Tolterodine—Atomoxetine—HTR2A—epilepsy syndrome	2.32e-05	0.0108	CrCbGaD
Tolterodine—Atomoxetine—CYP2D6—epilepsy syndrome	2.12e-05	0.00986	CrCbGaD
Tolterodine—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	2.09e-06	4.53e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	2.08e-06	4.51e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	2.06e-06	4.48e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—CAT—epilepsy syndrome	2.06e-06	4.47e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	2.06e-06	4.46e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—HTR2A—epilepsy syndrome	2.05e-06	4.45e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	2.04e-06	4.42e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TSC2—epilepsy syndrome	2.03e-06	4.42e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—AGT—epilepsy syndrome	2.03e-06	4.41e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.03e-06	4.41e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.03e-06	4.41e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	2.02e-06	4.39e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.01e-06	4.36e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ABCB1—epilepsy syndrome	2e-06	4.35e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	2e-06	4.35e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	2e-06	4.33e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—APOE—epilepsy syndrome	1.99e-06	4.32e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.99e-06	4.32e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	1.98e-06	4.29e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	1.96e-06	4.27e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	1.96e-06	4.25e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	1.95e-06	4.24e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—KDR—epilepsy syndrome	1.95e-06	4.23e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TSC2—epilepsy syndrome	1.95e-06	4.23e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.95e-06	4.23e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	1.95e-06	4.22e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—AGT—epilepsy syndrome	1.95e-06	4.22e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	1.94e-06	4.21e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	1.93e-06	4.18e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.92e-06	4.17e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	1.92e-06	4.17e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	1.91e-06	4.15e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	1.91e-06	4.15e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.91e-06	4.15e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—APOE—epilepsy syndrome	1.91e-06	4.14e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	1.9e-06	4.13e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.9e-06	4.13e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	1.89e-06	4.11e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	1.89e-06	4.09e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PRKCB—epilepsy syndrome	1.88e-06	4.08e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.87e-06	4.07e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.87e-06	4.06e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IL6ST—epilepsy syndrome	1.87e-06	4.06e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—KDR—epilepsy syndrome	1.87e-06	4.06e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GPX1—epilepsy syndrome	1.86e-06	4.04e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.86e-06	4.04e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.85e-06	4.03e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.84e-06	4e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.83e-06	3.97e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.83e-06	3.97e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.82e-06	3.96e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	1.81e-06	3.94e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	1.81e-06	3.93e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PRKCB—epilepsy syndrome	1.8e-06	3.9e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	1.8e-06	3.9e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	1.79e-06	3.89e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	1.79e-06	3.89e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	1.79e-06	3.89e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IL6ST—epilepsy syndrome	1.79e-06	3.89e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	1.79e-06	3.88e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	1.77e-06	3.85e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	1.77e-06	3.84e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.75e-06	3.81e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.74e-06	3.77e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	1.74e-06	3.77e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	1.73e-06	3.76e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.73e-06	3.75e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	1.71e-06	3.72e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—POMC—epilepsy syndrome	1.71e-06	3.71e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.7e-06	3.7e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CCL2—epilepsy syndrome	1.67e-06	3.63e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.67e-06	3.62e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.66e-06	3.61e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.65e-06	3.58e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	1.64e-06	3.56e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—POMC—epilepsy syndrome	1.64e-06	3.56e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	1.64e-06	3.55e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—AGT—epilepsy syndrome	1.63e-06	3.55e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.63e-06	3.54e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—TH—epilepsy syndrome	1.63e-06	3.53e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	1.62e-06	3.52e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CCL2—epilepsy syndrome	1.6e-06	3.48e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.6e-06	3.48e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—APOE—epilepsy syndrome	1.6e-06	3.47e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.6e-06	3.47e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	1.6e-06	3.46e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	1.59e-06	3.45e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.59e-06	3.45e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	1.59e-06	3.45e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	1.59e-06	3.45e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	1.58e-06	3.44e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.58e-06	3.44e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	1.58e-06	3.43e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.58e-06	3.42e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	1.58e-06	3.42e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	1.57e-06	3.41e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	1.57e-06	3.4e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.54e-06	3.34e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.54e-06	3.34e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.53e-06	3.33e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	1.53e-06	3.32e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.52e-06	3.29e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	1.52e-06	3.29e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.51e-06	3.29e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—FGF2—epilepsy syndrome	1.51e-06	3.28e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	1.51e-06	3.28e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.5e-06	3.27e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.5e-06	3.26e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	1.5e-06	3.25e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—TH—epilepsy syndrome	1.5e-06	3.25e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.49e-06	3.23e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—TH—epilepsy syndrome	1.48e-06	3.22e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	1.48e-06	3.2e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	1.47e-06	3.19e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.46e-06	3.17e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	1.46e-06	3.16e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—FGF2—epilepsy syndrome	1.45e-06	3.14e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	1.44e-06	3.13e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	1.44e-06	3.12e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	1.43e-06	3.09e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—RELA—epilepsy syndrome	1.4e-06	3.05e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MTOR—epilepsy syndrome	1.38e-06	2.99e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—POMC—epilepsy syndrome	1.37e-06	2.98e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	1.37e-06	2.98e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	1.37e-06	2.97e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	1.37e-06	2.97e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	1.37e-06	2.97e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.36e-06	2.95e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	1.35e-06	2.94e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	1.35e-06	2.94e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—RELA—epilepsy syndrome	1.34e-06	2.92e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	1.34e-06	2.91e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—CAT—epilepsy syndrome	1.34e-06	2.91e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	1.34e-06	2.91e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	1.33e-06	2.88e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MTOR—epilepsy syndrome	1.32e-06	2.86e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	1.32e-06	2.86e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	1.31e-06	2.85e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	1.3e-06	2.83e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	1.3e-06	2.82e-05	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—AKT1—epilepsy syndrome	1.28e-06	2.77e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CASP3—epilepsy syndrome	1.27e-06	2.75e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	1.27e-06	2.75e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	1.26e-06	2.74e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	1.26e-06	2.74e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	1.26e-06	2.73e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.26e-06	2.72e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ALB—epilepsy syndrome	1.25e-06	2.72e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	1.25e-06	2.71e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.25e-06	2.71e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	1.24e-06	2.7e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.24e-06	2.69e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.23e-06	2.67e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—JUN—epilepsy syndrome	1.23e-06	2.67e-05	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	1.22e-06	2.66e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.22e-06	2.66e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.22e-06	2.65e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.22e-06	2.64e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CASP3—epilepsy syndrome	1.21e-06	2.63e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.21e-06	2.63e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.2e-06	2.6e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MMP9—epilepsy syndrome	1.2e-06	2.6e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.19e-06	2.58e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	1.18e-06	2.56e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	1.16e-06	2.52e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	1.15e-06	2.5e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	1.15e-06	2.5e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	1.15e-06	2.49e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	1.14e-06	2.47e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	1.13e-06	2.45e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	1.12e-06	2.44e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	1.11e-06	2.42e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.11e-06	2.42e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	1.11e-06	2.41e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.1e-06	2.4e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	1.1e-06	2.4e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.1e-06	2.38e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PTGS2—epilepsy syndrome	1.1e-06	2.38e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	1.07e-06	2.33e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.06e-06	2.31e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	1.06e-06	2.29e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.04e-06	2.27e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.04e-06	2.26e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.04e-06	2.26e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	1.03e-06	2.23e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	1.02e-06	2.21e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	1.02e-06	2.21e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	1.01e-06	2.19e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	9.92e-07	2.15e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	9.81e-07	2.13e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—TH—epilepsy syndrome	9.78e-07	2.12e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—AGT—epilepsy syndrome	9.77e-07	2.12e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—AGT—epilepsy syndrome	9.68e-07	2.1e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—APOE—epilepsy syndrome	9.57e-07	2.08e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—APOE—epilepsy syndrome	9.49e-07	2.06e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	9.47e-07	2.06e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	9.44e-07	2.05e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	9.34e-07	2.03e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	9.28e-07	2.02e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	9.25e-07	2.01e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	9.16e-07	1.99e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—POMC—epilepsy syndrome	8.94e-07	1.94e-05	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	8.62e-07	1.87e-05	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	8.59e-07	1.87e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	8.54e-07	1.85e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	8.51e-07	1.85e-05	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	8.51e-07	1.85e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	8.43e-07	1.83e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	8.29e-07	1.8e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	8.27e-07	1.79e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—POMC—epilepsy syndrome	8.22e-07	1.78e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	8.19e-07	1.78e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	8.16e-07	1.77e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—POMC—epilepsy syndrome	8.15e-07	1.77e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ALB—epilepsy syndrome	8.15e-07	1.77e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	8.07e-07	1.75e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—CAT—epilepsy syndrome	8.05e-07	1.75e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	8.04e-07	1.75e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	7.97e-07	1.73e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	7.83e-07	1.7e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	7.83e-07	1.7e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	7.8e-07	1.69e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	7.73e-07	1.68e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ALB—epilepsy syndrome	7.49e-07	1.63e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	7.44e-07	1.62e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ALB—epilepsy syndrome	7.43e-07	1.61e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	7.42e-07	1.61e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	7.34e-07	1.59e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	7.28e-07	1.58e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	7.25e-07	1.57e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	7.22e-07	1.57e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	7.15e-07	1.55e-05	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	7.13e-07	1.55e-05	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	6.86e-07	1.49e-05	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	6.57e-07	1.43e-05	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	6.56e-07	1.42e-05	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	6.5e-07	1.41e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AGT—epilepsy syndrome	6.39e-07	1.39e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—APOE—epilepsy syndrome	6.26e-07	1.36e-05	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—AKT1—epilepsy syndrome	5.51e-07	1.2e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.37e-07	1.17e-05	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ALB—epilepsy syndrome	4.9e-07	1.06e-05	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	4.62e-07	1e-05	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	4.61e-07	1e-05	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	4.56e-07	9.91e-06	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.29e-07	9.31e-06	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	3.58e-07	7.78e-06	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.3e-07	7.15e-06	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	3.27e-07	7.09e-06	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.15e-07	4.68e-06	CbGpPWpGaD
